(Q41164333)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869846%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

review article

1 reference

title

Epidemiology, control and treatment of multidrug-resistant tuberculosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869846%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

main subject

multiple drug resistance

1 reference

P Chaulet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869846%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M Raviglione

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869846%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

F Bustreo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869846%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869846%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869846%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

52 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869846%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

103-7; discussion 107-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8869846%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-199600522-00021

20 October 2019

exact match

0 references

cites work

[Possible causes of the failure of the treatment of pulmonary tuberculosis ; how to avoid them]

1 reference

12 December 2020

Surveillance of drug resistance for tuberculosis control: why and how?

1 reference

12 December 2020

Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease

1 reference

12 December 2020

A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Resea

1 reference

12 December 2020

[Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months]

1 reference

12 December 2020

Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council

1 reference

12 December 2020

Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment

1 reference

12 December 2020

Human bioavailability studies

1 reference

12 December 2020

The supply of antituberculosis drugs and national drugs policies.

1 reference

12 December 2020

[Clinical trial of a combination of three drugs in fixed proportions in the treatment of tuberculosis. Groupe de Travail sur la Chimiothérapie de la Tuberculose]

1 reference

12 December 2020

Multidrug-resistant tuberculosis and its control

1 reference

12 December 2020

Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria. Algerian Working Group/British Medical Research Council Cooperative Study

1 reference

12 December 2020